FDA Panel Rejects Xyrem as Fibromyalgia Treatment
FDA Panel Rejects Xyrem as Fibromyalgia Treatment Advisory Panel Members Worry About Potential for Abuse of Drug That's Similar to GHB WebMD Medical News By Matt McMillen Reviewed by Laura...
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.